RAFAEL HOLDINGS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
RAFAEL HOLDINGS, INC. (RFL) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$639.00 thousand for the 12-month period ending 2023-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-07-31 was $48.00K, a 90.14% decline year-over-year.
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-01-31 was -$266.00K.
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2022-10-31 was -$421.00K.
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was -$639.00K.
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was -$41.00K.
- RAFAEL HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2021 was -$287.00K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2023-07-31 | $48.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $48.00K derived: sum of 2 quarters · filed 2024-12-20 | -$218.00K derived: sum of 3 quarters · filed 2024-12-20 | -$639.00K 10-K/A · filed 2024-12-20 |
| 2023-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$266.00K derived: sum of 2 quarters · filed 2024-06-14 | -$687.00K 10-Q · filed 2024-06-14 | -$200.00K derived: sum of 4 quarters · filed 2024-06-14 |
| 2023-01-31 | -$266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | -$687.00K 10-Q · filed 2024-03-14 | -$200.00K derived: sum of 3 quarters · filed 2024-03-14 | -$403.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-10-31 | -$421.00K 10-Q · filed 2023-12-14 | $66.00K derived: sum of 2 quarters · filed 2023-12-14 | -$137.00K derived: sum of 3 quarters · filed 2023-12-14 | -$282.00K derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $284.00K derived: sum of 2 quarters · filed 2023-10-30 | $139.00K derived: sum of 3 quarters · filed 2023-10-30 | -$41.00K 10-K · filed 2023-10-30 |
| 2022-04-30 | -$203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$348.00K derived: sum of 2 quarters · filed 2023-06-13 | -$528.00K 10-Q · filed 2023-06-13 | |
| 2022-01-31 | -$145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$325.00K 10-Q · filed 2023-03-14 | ||
| 2021-10-31 | -$180.00K 10-Q · filed 2022-12-13 | |||
| 2021-07-31 | -$287.00K 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |